BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

370 related articles for article (PubMed ID: 24717829)

  • 1. Pancreatic enzyme replacement therapy in patients with exocrine pancreatic insufficiency due to chronic pancreatitis: a 1-year disease management study on symptom control and quality of life.
    D'Haese JG; Ceyhan GO; Demir IE; Layer P; Uhl W; Löhr M; Rychlik R; Pirilis K; Zöllner Y; Gradl B; Foerster D; Möbius J; Henniges F; Friess H
    Pancreas; 2014 Aug; 43(6):834-41. PubMed ID: 24717829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exocrine pancreatic insufficiency following esophagectomy.
    Huddy JR; Macharg FM; Lawn AM; Preston SR
    Dis Esophagus; 2013 Aug; 26(6):594-7. PubMed ID: 23199208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness analysis of pancreatin minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Morawski JH; Prüfert A; van Engen A; Foerster D; Sander-Struckmeier S; Małecka-Panas E; Pezzilli R
    J Med Econ; 2012; 15 Suppl 1():15-25. PubMed ID: 23043594
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effectiveness of pancreatic enzyme replacement therapy using microencapsulated pancreatin preparations in the correction of nutritional status in patients with chronic pancreatitis: a prospective observational study].
    Bideeva TV; Maev IV; Kucheryavyy YA; Andreev DN; Shah YS; Lobanova EG; Zaborovskiy AV; Levchenko AI
    Ter Arkh; 2020 Jan; 92(1):30-35. PubMed ID: 32598660
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and Safety of Pancrelipase/Pancreatin in Patients With Exocrine Pancreatic Insufficiency and a Medical History of Diabetes Mellitus.
    Whitcomb DC; Bodhani A; Beckmann K; Sander-Struckmeier S; Liu S; Fuldeore M; Pollack PF; Khurmi RP
    Pancreas; 2016; 45(5):679-86. PubMed ID: 26495784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 6-month, open-label clinical trial of pancrelipase delayed-release capsules (Creon) in patients with exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery.
    Gubergrits N; Malecka-Panas E; Lehman GA; Vasileva G; Shen Y; Sander-Struckmeier S; Caras S; Whitcomb DC
    Aliment Pharmacol Ther; 2011 May; 33(10):1152-61. PubMed ID: 21418260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancrelipase delayed-release capsules (CREON) for exocrine pancreatic insufficiency due to chronic pancreatitis or pancreatic surgery: A double-blind randomized trial.
    Whitcomb DC; Lehman GA; Vasileva G; Malecka-Panas E; Gubergrits N; Shen Y; Sander-Struckmeier S; Caras S
    Am J Gastroenterol; 2010 Oct; 105(10):2276-86. PubMed ID: 20502447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patients with exocrine insufficiency due to chronic pancreatitis are undertreated: a Dutch national survey.
    Sikkens EC; Cahen DL; van Eijck C; Kuipers EJ; Bruno MJ
    Pancreatology; 2012; 12(1):71-3. PubMed ID: 22487479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pain severity reduces life quality in chronic pancreatitis: Implications for design of future outcome trials.
    Olesen SS; Juel J; Nielsen AK; Frøkjær JB; Wilder-Smith OH; Drewes AM
    Pancreatology; 2014; 14(6):497-502. PubMed ID: 25455540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CREON (Pancrelipase Delayed-Release Capsules) for the treatment of exocrine pancreatic insufficiency.
    Kuhn RJ; Gelrud A; Munck A; Caras S
    Adv Ther; 2010 Dec; 27(12):895-916. PubMed ID: 21086085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of exocrine pancreatic insufficiency in patients with chronic pancreatitis without follow-up. PANCR-EVOL Study.
    Marra-Lopez Valenciano C; Bolado Concejo F; Marín Serrano E; Millastre Bocos J; Martínez-Moneo E; Pérez Rodríguez E; Francisco González M; Del Pozo-García A; Hernández Martín A; Labrador Barba E; Orera Peña ML; de-Madaria E
    Gastroenterol Hepatol; 2018 Feb; 41(2):77-86. PubMed ID: 28935122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pancreatic enzyme replacement therapy in chronic pancreatitis.
    Sikkens EC; Cahen DL; Kuipers EJ; Bruno MJ
    Best Pract Res Clin Gastroenterol; 2010 Jun; 24(3):337-47. PubMed ID: 20510833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis--a double-blind, placebo-controlled study.
    Thorat V; Reddy N; Bhatia S; Bapaye A; Rajkumar JS; Kini DD; Kalla MM; Ramesh H
    Aliment Pharmacol Ther; 2012 Sep; 36(5):426-36. PubMed ID: 22762290
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative evaluation of a high lipase pancreatic enzyme preparation and a standard pancreatic supplement for treating exocrine pancreatic insufficiency in chronic pancreatitis.
    Delhaye M; Meuris S; Gohimont AC; Buedts K; Cremer M
    Eur J Gastroenterol Hepatol; 1996 Jul; 8(7):699-703. PubMed ID: 8853261
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of oral pancreatic enzyme supplementation on the course and outcome of acute pancreatitis: a randomized, double-blind parallel-group study.
    Kahl S; Schütte K; Glasbrenner B; Mayerle J; Simon P; Henniges F; Sander-Struckmeier S; Lerch MM; Malfertheiner P
    JOP; 2014 Mar; 15(2):165-74. PubMed ID: 24618443
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacotherapy of chronic pancreatitis in terms of current clinical recommendations.
    Maev IV; Bideeva ТВ; Kucheryavyy YA; Andreev DN; Bueverov AO
    Ter Arkh; 2018 Aug; 90(8):81-85. PubMed ID: 30701942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A 51-week, open-label clinical trial in India to assess the efficacy and safety of pancreatin 40000 enteric-coated minimicrospheres in patients with pancreatic exocrine insufficiency due to chronic pancreatitis.
    Ramesh H; Reddy N; Bhatia S; Rajkumar JS; Bapaye A; Kini D; Kalla M; Thorat V
    Pancreatology; 2013; 13(2):133-9. PubMed ID: 23561971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Quality of life in the course of enzyme replacement therapy for chronic pancreatitis].
    Czakó L; Takács T; Lonovics J; Lakner L; Döbrönte Z; Prónai L; Tulassay Z
    Orv Hetil; 2002 Jun; 143(25):1521-7. PubMed ID: 12577405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of pancreatic enzyme replacement therapy in chronic pancreatitis: systematic review and meta-analysis.
    de la Iglesia-García D; Huang W; Szatmary P; Baston-Rey I; Gonzalez-Lopez J; Prada-Ramallal G; Mukherjee R; Nunes QM; Domínguez-Muñoz JE; Sutton R;
    Gut; 2017 Aug; 66(8):1354-1355. PubMed ID: 27941156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of pancreatic enzyme supplementation on postprandial responses of glucagon-like Peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency.
    Knop FK; Vilsbøll T; Lund A; Krarup T; Holst JJ; Hornum M
    JOP; 2010 Sep; 11(5):489-91. PubMed ID: 20818126
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.